HIV treatment

Individual
results may vary.

How STRIBILD Can Help if You’re Replacing Your Current Treatment

If you are considering replacing your current HIV-1 treatment, STRIBILD can help keep your immune system strong by:

  • Maintaining an undetectable amount of HIV-1 in your blood (also called viral load)
  • Helping to maintain the number of infection-fighting CD4 T cells in your blood

STRIBILD was studied in 2 separate trials (called Study 115 and Study 121). To see an overview of the studies, click here. In these 2 studies, STRIBILD helped patients changing treatment maintain undetectable viral loads. The results of these studies are shown below.

In Study 115,

more than 9 out of 10 patients who switched to STRIBILD maintained undetectable viral loads at 1 year
of treatment

An undetectable viral load means having less than 50 copies per milliliter of the virus in your blood

  • In Study 115, the current HIV-1 medicines were a protease inhibitor, ritonavir, and the combination of emtricitabine and tenofovir disoproxil fumarate
  • STRIBILD worked equally as well as the other proven HIV-1 medicine
  • In this study, the difference in the results was largely due to the higher number of patients on the other approved HIV-1 medicine who dropped out of the study

Undetectable viral load results at 1 year of treatment

290 people replaced their medicine with STRIBILD and 94% maintained undetectable viral loads vs 139 people who took their current HIV-1 medicine and 87% maintained undetectable viral loads
  • At the onset of Study 115, the average CD4 T-cell count was 610 cells per cubic millimeter of blood
  • After 1 year of treatment, STRIBILD helped maintain CD4 T-cell counts as well as the other approved HIV-1 medicine

​STRIBILD does not cure HIV-1 infection or AIDS

HIV-1 is the virus that causes AIDS. There is no known cure for HIV-1 or AIDS. You must continue to take STRIBILD every day to control your HIV-1 infection and decrease illnesses caused by HIV-1 infection.

In Study 121,

more than 9 out of 10 patients who switched to STRIBILD maintained undetectable viral loads at 1 year
of treatment

An undetectable viral load means having less than 50 copies per milliliter of the virus in your blood

  • In Study 121, the current HIV-1 medicines were a non-nucleoside reverse transcriptase inhibitor and the combination of emtricitabine and tenofovir disoproxil fumarate
  • STRIBILD worked equally as well as the other proven HIV-1 medicine
  • In this study, the difference in the results was largely due to the higher number of patients on the other approved HIV-1 medicine who dropped out of the study

Undetectable viral load results at 1 year of treatment

290 people replaced their medicine with STRIBILD and 93% maintained undetectable viral loads vs 143 people who took their current HIV-1 medicine and 88% maintained undetectable viral loads
  • At the onset of Study 121, the average CD4 T-cell count was 588 cells per cubic millimeter of blood
  • After 1 year of treatment, STRIBILD helped maintain CD4 T-cell counts as well as the other approved HIV-1 medicine

Avoid doing things that can spread HIV-1 to other people

  • Do not share items that can have blood or body fluids on them, like needles, other injection equipment, razor blades, or toothbrushes
  • Always practice safer sex. Use protection, like latex or polyurethane condoms, when having any sexual contact

Ask your healthcare provider if you have any questions about how to prevent passing HIV-1 to other people.



IMPORTANT SAFETY INFORMATION

What is the most important information I should know about STRIBILD?

STRIBILD can cause serious side effects:

  • Build-up of an acid in your blood (lactic acidosis), which is a serious medical emergency. Symptoms of lactic acidosis include feeling very weak or tired, unusual (not normal) muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold especially in your arms and legs, feeling dizzy or lightheaded, and/or a fast or irregular heartbeat
  • Serious liver problems. The liver may become large (hepatomegaly) and fatty (steatosis). Symptoms of liver problems include your skin or the white part of your eyes turns yellow (jaundice), dark “tea-colored” urine, light-colored bowel movements (stools), loss of appetite for several days or longer, nausea, and/or stomach pain
  • You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight (obese), or have been taking STRIBILD for a long time. In some cases, these serious conditions have led to death. Call your healthcare provider right away if you have any symptoms of these conditions
  • Worsening of hepatitis B (HBV) infection. If you also have HBV and stop taking STRIBILD, your hepatitis may suddenly get worse. Do not stop taking STRIBILD without first talking to your healthcare provider, as they will need to monitor your health. STRIBILD is not approved for the treatment of HBV

What is STRIBILD?

STRIBILD® is a prescription medicine used to treat HIV-1 in adults who have never taken HIV-1 medicines before. STRIBILD can also replace current HIV-1 medicines for some adults who have an undetectable viral load (less than 50 copies/mL of virus in their blood) and whose healthcare provider determines that they meet certain other requirements. STRIBILD combines 4 medicines into 1 pill to be taken once a day with food. STRIBILD is a complete single tablet regimen and should not be used with other HIV-1 medicines.

STRIBILD does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses you must keep taking STRIBILD. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

The information in this section is intended for residents of the United States who are 18 years of age or older.

By following this link, you are now leaving
www.STRIBILD.com. This site is not controlled
by Gilead Sciences, Inc. Gilead Sciences, Inc. is not
responsible for the site's content or your use of it.

GET UPDATES

Sign up to receive updates when new information on STRIBILD is made available.


Submit

Terms and conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. For more information regarding our Privacy Policy, click here.
Print

Thank you.

You will be notified as new information is made available on this Web site.